Topco Scientific Co.,Ltd. (TPE:5434)
Taiwan · Delayed Price · Currency is TWD 331.50
+9.00 (2.79%)
Apr 2, 2026, 1:30 PM CST
Topco Scientific Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 65,271 | 54,768 | 46,944 | 50,555 | 41,098 |
Other Revenue | 2,312 | 2,229 | 2,329 | 2,423 | 1,571 |
| 67,584 | 56,997 | 49,273 | 52,978 | 42,669 | |
Revenue Growth (YoY) | 18.57% | 15.68% | -6.99% | 24.16% | 17.97% |
Cost of Revenue | 58,933 | 49,279 | 42,855 | 46,453 | 37,457 |
Gross Profit | 8,650 | 7,718 | 6,419 | 6,525 | 5,212 |
Selling, General & Admin | 4,140 | 3,712 | 3,091 | 3,139 | 2,559 |
Research & Development | 52.02 | 66.64 | 117.48 | 156.41 | 101.17 |
Other Operating Expenses | -1.38 | -4.26 | 12.02 | -0.29 | -0.29 |
Operating Expenses | 4,190 | 3,775 | 3,221 | 3,296 | 2,660 |
Operating Income | 4,460 | 3,943 | 3,198 | 3,230 | 2,552 |
Interest Expense | -92.07 | -113.68 | -99.57 | -53.11 | -34.23 |
Interest & Investment Income | 193.07 | 159.92 | 190.85 | 122.91 | 60.98 |
Earnings From Equity Investments | 501.95 | 609.81 | 471.82 | 541.72 | 422.68 |
Currency Exchange Gain (Loss) | -85.7 | 8.45 | -13.74 | 123.55 | -38.39 |
Other Non Operating Income (Expenses) | 72.73 | 78.45 | 78.86 | 54.96 | 50.18 |
EBT Excluding Unusual Items | 5,050 | 4,686 | 3,826 | 4,020 | 3,013 |
Merger & Restructuring Charges | - | - | - | - | -0.12 |
Gain (Loss) on Sale of Investments | 431.02 | 83.76 | 80.15 | 248.5 | 45.27 |
Gain (Loss) on Sale of Assets | -6.91 | -10.25 | -26.11 | -26.65 | -8.53 |
Asset Writedown | -10.96 | -30.4 | - | - | -10.03 |
Pretax Income | 5,463 | 4,729 | 3,880 | 4,242 | 3,040 |
Income Tax Expense | 1,271 | 1,064 | 1,028 | 1,167 | 738.89 |
Earnings From Continuing Operations | 4,192 | 3,665 | 2,853 | 3,075 | 2,301 |
Minority Interest in Earnings | -11.58 | -9.16 | -17.89 | -56.7 | -6.5 |
Net Income | 4,180 | 3,656 | 2,835 | 3,018 | 2,294 |
Net Income to Common | 4,180 | 3,656 | 2,835 | 3,018 | 2,294 |
Net Income Growth | 14.35% | 28.96% | -6.08% | 31.55% | 10.93% |
Shares Outstanding (Basic) | 192 | 190 | 185 | 182 | 182 |
Shares Outstanding (Diluted) | 196 | 195 | 189 | 184 | 183 |
Shares Change (YoY) | 0.18% | 3.29% | 2.84% | 0.48% | -0.09% |
EPS (Basic) | 21.81 | 19.29 | 15.36 | 16.61 | 12.63 |
EPS (Diluted) | 21.40 | 18.78 | 15.03 | 16.41 | 12.53 |
EPS Growth | 13.93% | 24.93% | -8.39% | 30.97% | 10.98% |
Free Cash Flow | 3,986 | 866.68 | -152.61 | 2,815 | 2,191 |
Free Cash Flow Per Share | 20.37 | 4.44 | -0.81 | 15.30 | 11.97 |
Dividend Per Share | 13.500 | 11.990 | 10.000 | 10.000 | 8.800 |
Dividend Growth | 12.59% | 19.90% | - | 13.64% | 10.00% |
Gross Margin | 12.80% | 13.54% | 13.03% | 12.32% | 12.21% |
Operating Margin | 6.60% | 6.92% | 6.49% | 6.10% | 5.98% |
Profit Margin | 6.19% | 6.41% | 5.75% | 5.70% | 5.38% |
Free Cash Flow Margin | 5.90% | 1.52% | -0.31% | 5.31% | 5.14% |
EBITDA | 4,789 | 4,261 | 3,526 | 3,547 | 2,816 |
EBITDA Margin | 7.09% | 7.48% | 7.16% | 6.69% | 6.60% |
D&A For EBITDA | 329.3 | 318.03 | 327.86 | 316.89 | 263.9 |
EBIT | 4,460 | 3,943 | 3,198 | 3,230 | 2,552 |
EBIT Margin | 6.60% | 6.92% | 6.49% | 6.10% | 5.98% |
Effective Tax Rate | 23.27% | 22.50% | 26.48% | 27.50% | 24.31% |
Revenue as Reported | 67,584 | 56,997 | 49,273 | 52,978 | 42,669 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.